Page last updated: 2024-10-23

bisoprolol and Cyanosis

bisoprolol has been researched along with Cyanosis in 1 studies

Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.

Cyanosis: A bluish or purplish discoloration of the skin and mucous membranes due to an increase in the amount of deoxygenated hemoglobin in the blood or a structural defect in the hemoglobin molecule.

Research Excerpts

ExcerptRelevanceReference
"Treatment with bisoprolol is recommended in symptomatic children and also improved symptoms in our patient."1.31Bisoprolol treatment for cyanotic spells--a 69-year-old female with uncorrected pentalogy of Fallot. ( Anders, HJ; Fuchshuber, S, 2001)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anders, HJ1
Fuchshuber, S1

Other Studies

1 other study available for bisoprolol and Cyanosis

ArticleYear
Bisoprolol treatment for cyanotic spells--a 69-year-old female with uncorrected pentalogy of Fallot.
    European journal of medical research, 2001, Jun-28, Volume: 6, Issue:6

    Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Child; Cyanosis; Female; Heart Septal Defects, Atrial

2001